Clinical Trials Logo

Hyperalgesia clinical trials

View clinical trials related to Hyperalgesia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06096181 Not yet recruiting - Dexmedetomidine Clinical Trials

Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery

Start date: December 2023
Phase: Phase 2
Study type: Interventional

Patients with Adolescent Idiopathic Scoliosis may need surgery to correct their scoliosis. General anesthesia is required for this surgery, and a multimodal analgesic regimen using combinations of opioid and non-opioid medications is the standard of care. The purpose of this study is to compare two combinations of total intravenous anesthetic medications in children with Adolescent Idiopathic Scoliosis having posterior spinal fusion surgery. Participants in the study will be randomly selected to receive either Propofol and Remifentanil or Propofol and Dexmedetomidine as their total intravenous anesthesia (TIVA). TIVA is favored over gas anesthesia because gas anesthesia can affect the neurological monitoring necessary for this surgery. The first combination (Propofol + Remifentanil) is the most common one used for this surgery at our institution, and the second combination (Propofol + Dexmedetomidine) is more commonly used in adult spine surgery. Though Dexmedetomidine is not approved for pediatric use by the FDA, it is widely used in pediatric patients for procedural sedation and surgical anesthesia in the US and worldwide. Both anesthetic combinations are used safely in adult and pediatric patients at our institution. Although remifentanil works fast and is an excellent pain medication during surgery, there are reports that it's use can cause increased pain sensitivity and greater need for narcotic pain medication after surgery. This phenomenon is known as opioid-induced hyperalgesia. The investigators hypothesize that avoiding the use of remifentanil in the TIVA by using dexmedetomidine could avoid OIH and thus result in superior postop pain control. Our study's primary goal is to measure the total opioid consumption on postoperative days (POD)# 0 and 1. Our secondary goals are to measure the pain scores on a visual analog scale (VAS) on POD# 0 and 1, measure the time it takes for participants to move their feet to command when surgery is done, and measure the time it takes for participants to be extubated when surgery is done. By comparing these measurements, the investigators hope to find out if there is any significant difference between the two TIVAs in terms of postop opioid requirements, pain scores, and time to wake up from anesthesia. The investigators hope that our study gives us more knowledge on how to better treat postoperative pain in children who have spine surgery to correct their

NCT ID: NCT05028049 Not yet recruiting - Anesthesia Clinical Trials

Comparison of Remifentanil-induced Postoperative Hyperalgesia Between Patients From Plain Area and Plateau Area

Start date: August 30, 2021
Phase:
Study type: Observational [Patient Registry]

Purpose: 1. To compare the incidence of postoperative hyperalgesia induced by remifentanil in patients undergoing gynecological laparoscopic surgery in plateau and plain areas 2. To compare the peri-operative analgesic requirements of patients in plain and plateau areas

NCT ID: NCT04580641 Not yet recruiting - Migraine Clinical Trials

Validation of a Questionnaire for Allodynia in Migraine.

Q-MIGAL
Start date: October 1, 2020
Phase:
Study type: Observational

Migraine is very frequent (15% of the general population). During attacks, many subjects with migraine have allodynia (pain induced by normally non-painful stimuli), photophobia (hypersensitivity to light), phonophobia (hypersensitivity to sound) or osmophobia (hypersensitivity to odours). The goal of the present study is to validate a new questionnaire made of 4 parts evaluating the presence of these 4 types of hypersensitivity, both during or between migraine attacks. It will allow to look for associations of these 4 symptoms and association of hypersensitivity with patients' or migraine's characteristics.

NCT ID: NCT03875261 Not yet recruiting - Endometriosis Clinical Trials

Effect of Cannabinoid (THC / CBD 50%) on Hyperalgesia in Patients With Deep Endometriosis

EdomTHC
Start date: April 1, 2019
Phase: Phase 2
Study type: Interventional

This study evaluates the treatment of the symptoms of deep endometriosis with a cannabinoid derivate.

NCT ID: NCT03164161 Not yet recruiting - Hyperalgesia Clinical Trials

The Relationship Between Saliva β-endorphins Levels, Cold Pressor Test and Perception of Pain in Oral Surgery Procedures

Start date: May 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the correlation between β-endorphin levels in blood plasma and saliva in healthy participants with different pain sensitivity and in those with acute pain in oral and maxillofacial region. Expected results - Relation between blood plasma and saliva β-endorphins levels - Differences of blood plasma β-endorphins levels in healthy participants with different pain sensitivity and in those with acute pain - Differences of saliva β-endorphins levels in healthy participants with different pain sensitivity and in those with acute pain - Objective method of patient's pain sensation evaluation - Correlation between patient's self-reported understanding of pain levels in oral surgery procedures, levels in saliva and blood plasma β-endorphins levels and sensitivity to cold test results Study protocol: Selection of participants 1. Evaluation of pain perception in oral surgery procedures by healthy adult participants. 2. Groups formation, according to the results from first stage, resulting in high and low pain rating participants groups. 3. Control group formation from patients with acute pain in oral and maxillofacial region Control rating of participants 1. Patients that have been assigned to groups according to subjective pain ratings in oral surgery procedures will have to repeat the same questionnaire to ensure the correct group assignment. 2. Patients that have been assigned to groups according to subjective pain ratings in oral surgery procedures, will undergo the sensitivity and tolerance to cold pain test. 3. Patients that were assigned to control-acute pain group, will be included in further study stages only with clinically diagnosed cause of acute pain in oral and maxillofacial region to avoid possible psychogenic or general diseases pain. Evaluation of β-endorphins - sampling 1. Saliva samples will be collected by all further included participants by one selves participants with researchers supervision. 2. Blood samples will be collected from forearm veins by researcher. Evaluation of β-endorphins - laboratorial examination 1. Levels of β-endorphins in saliva and blood will be evaluated according to manufacturer of β-endorphins evaluation kit for human research. Every sample will be evaluated twice and the mean level will be evaluated. Statistical analysis 1. Statistical analysis will be produced to access all possible relationships

NCT ID: NCT02934763 Not yet recruiting - Hyperalgesia Clinical Trials

Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Opioid Induced Hyperalgesia (OIH) is an entity than has been demonstrated in healthy volunteers and in animal models. Is defined as an increase in the perception to painful stimuli, increasing the opioid requirements and diminishing the pain thresholds to stimuli. The apparition of OIH is also related to the exposure to opioids during surgery, depending of the dose, the time of exposition and the type of opioid. This condition can be modulated, specially in the perioperative context. It has been seen in healthy volunteers and in animal models, than the use of propranolol can modulate this phenomena, diminishing the postoperative requirements of analgesia. It is also unknown, the dose of propranolol required to modulate adequately OIH. The objective of this work is to evaluate the efficacy of propranolol in the modulation of opioid induced hyperalgesia, with lower postoperative requirements of analgesia rescue.

NCT ID: NCT02087202 Not yet recruiting - Pain Clinical Trials

Hyperalgesia and NMDA Receptor Antagonist

Start date: March 2014
Phase: N/A
Study type: Interventional

NMDA receptor is administered and postoperative remote hyperalgesia is investigated.